411 related articles for article (PubMed ID: 21304061)
1. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
[TBL] [Abstract][Full Text] [Related]
2. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
[TBL] [Abstract][Full Text] [Related]
3. A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats.
Liu SZ; Sun D; Zhang GY; Wang L; Liu T; Sun Y; Li MX; Hu SY
Chin Med J (Engl); 2012 Mar; 125(5):912-9. PubMed ID: 22490596
[TBL] [Abstract][Full Text] [Related]
4. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
[TBL] [Abstract][Full Text] [Related]
5. Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.
Weng S; Zhang B; Xu C; Feng S; He H
Obes Surg; 2017 Mar; 27(3):657-664. PubMed ID: 27525641
[TBL] [Abstract][Full Text] [Related]
6. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
7. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.
Geloneze B; Geloneze SR; Chaim E; Hirsch FF; Felici AC; Lambert G; Tambascia MA; Pareja JC
Ann Surg; 2012 Jul; 256(1):72-8. PubMed ID: 22664560
[TBL] [Abstract][Full Text] [Related]
8. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
[TBL] [Abstract][Full Text] [Related]
9. [Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].
Wang Y; Zhang ZZ; Wang L; Deng ZZ; Jiao YB; Zou ZD
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2858-61. PubMed ID: 20137669
[TBL] [Abstract][Full Text] [Related]
10. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
[TBL] [Abstract][Full Text] [Related]
11. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
Movassat J; Saulnier C; Serradas P; Portha B
Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986
[TBL] [Abstract][Full Text] [Related]
12. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
13. The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.
Kindel TL; Yoder SM; D'Alessio DA; Tso P
Obes Surg; 2010 Jun; 20(6):768-75. PubMed ID: 20177809
[TBL] [Abstract][Full Text] [Related]
14. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.
Wang TT; Hu SY; Gao HD; Zhang GY; Liu CZ; Feng JB; Frezza EE
Ann Surg; 2008 Jun; 247(6):968-75. PubMed ID: 18520224
[TBL] [Abstract][Full Text] [Related]
15. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
[TBL] [Abstract][Full Text] [Related]
16. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
17. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
[TBL] [Abstract][Full Text] [Related]
18. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.
Patriti A; Facchiano E; Annetti C; Aisa MC; Galli F; Fanelli C; Donini A
Obes Surg; 2005 Oct; 15(9):1258-64. PubMed ID: 16259883
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats.
Svensson AM; Ostenson CG; Efendic S; Jansson L
Clin Sci (Lond); 2007 Jun; 112(6):345-51. PubMed ID: 17087662
[TBL] [Abstract][Full Text] [Related]
20. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
